Micronclean has announced the completion of its investment in its ISO Class 5/ GMP B Cleanroom Laundry facility in Bangalore
From Left to Right: Andrew Cole, Managing Director of Micronclean India PVT LTD; Alex Ellis, British High Commissioner to India; Mr Chandra Reddy Mareddy, Hetero organisation
This important milestone was marked by an official cleanroom garment hand-over at the British Deputy High Commissioner’s residence in Bangalore an event that was attended by Alex Ellis, British High Commissioner to India, Deputy High Commissioner Anna Shotbolt, Andrew Cole, Managing Director of Micronclean India PVT LTD and senior industry stakeholders Kiran Mazumdar Shaw, Prasad S. Deshpande, Parag Deshpande and Smt. Uma Mahadevan, IAS - Principal Secretary, Rural Development, Govt of Karnataka. The ceremony marked the end of Micronclean £8 million-pound (80Crore Rupees) investment in a brand-new purpose-built Cleanroom Laundry in Bangalore which is unique in India. The facility uses Micronclean’s proven process technologies to deliver GMP compliant clean sterile garments which are ready to wear and can be shipped direct to pharmaceutical and biotechnology customers across southern India.
The celebrations were further enhanced by the signing of a contract to supply cleanroom garment services to Hetero Labs, who were represented by Mr Chandra Reddy Mareddy a senior official from the Hyderabad based Hetero organisation.
Andrew Cole, Managing Director of Micronclean India said: “We are delighted to have successfully completed the investment and delivered a world leading facility that can support the ever-growing Indian pharmaceutical industry.”
“At certain stages especially during the height of the pandemic it seemed like we might never reach this point and so I must pay tribute to all the teams that have been involved in this development both here in India, in the UK and our equipment suppliers from around the world.”
“In conclusion I have to say that I am really excited to be part of this ceremony that celebrates not only the hard work put in to create an operational plant but also its success measured by the number of customers who have placed long term commercial contracts. These contracts cover all aspects of Indian pharmaceutical and biotechnology manufacturing including Covid-19 vaccine manufacture.”
British Deputy High Commissioner to India Anna Shotbolt said, “The need for collaboration on healthcare between nations has never been more important. This latest investment by Micronclean and the successful completion of the Vemagal facility reaffirms the UK’s global commitment to support the pharmaceutical industry in fighting the pandemic. I look forward to seeing more plants like these to bring the best minds from the UK and India together further still.”